A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)
Clinical trial NCT07768592 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07768592
- Sponsor
- Eisai Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-15
- Primary completion
- 2030-05-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.